Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

被引：0
|
作者：
Hrzenjak, A. [1 ]
Moinfar, F. [2 ]
Kremser, M. L. [2 ]
Strohmeier, B. [2 ]
Petru, E. [3 ]
Zatloukal, K. [2 ]
Denk, H. [2 ]
机构：
[1] Med Univ Graz, Inst Internal Med, Clin Dept Pulmonol, Graz, Austria
[2] Med Univ Graz, Dept Pathol, Graz, Austria
[3] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71055-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
248
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
    Andelko Hrzenjak
    Farid Moinfar
    Marie-Luise Kremser
    Bettina Strohmeier
    Edgar Petru
    Kurt Zatloukal
    Helmut Denk
    Molecular Cancer, 9
  • [2] Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo
    Hrzenjak, Andelko
    Moinfar, Farid
    Kremser, Marie-Luise
    Strohmeier, Bettina
    Petru, Edgar
    Zatloukal, Kurt
    Denk, Helmut
    MOLECULAR CANCER, 2010, 9
  • [3] Significant growth suppression of synovial sarcomas by the histone deacetylase inhibitor FK228 in vitro and in vivo
    Ito, T
    Ouchida, M
    Morimoto, Y
    Yoshida, A
    Jitsumori, Y
    Ozaki, T
    Sonobe, H
    Inoue, H
    Shimizu, K
    CANCER LETTERS, 2005, 224 (02) : 311 - 319
  • [4] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
    Butler, LM
    Agus, DB
    Scher, HI
    Higgins, B
    Rose, A
    Cordon-Cardo, C
    Thaler, HT
    Rifkind, RA
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2000, 60 (18) : 5165 - 5170
  • [5] Combination therapy with a histone-deacetylase inhibitor and an angiogenesis inhibitor potently suppresses HCC growth in vitro and in vivo.
    Herold, C
    Ganslmayer, M
    Ocker, M
    Williams, J
    Hahn, EG
    Schuppan, D
    HEPATOLOGY, 2001, 34 (04) : 500A - 500A
  • [6] The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
    Buckley, Michael T.
    Yoon, Joanne
    Yee, Herman
    Chiriboga, Luis
    Liebes, Leonard
    Ara, Gulshan
    Qian, Xiaozhong
    Bajorin, Dean F.
    Sun, Tung-Tien
    Wu, Xue-Ru
    Osman, Iman
    JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5 (1)
  • [7] The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
    Michael T Buckley
    Joanne Yoon
    Herman Yee
    Luis Chiriboga
    Leonard Liebes
    Gulshan Ara
    Xiaozhong Qian
    Dean F Bajorin
    Tung-Tien Sun
    Xue-Ru Wu
    Iman Osman
    Journal of Translational Medicine, 5
  • [8] In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?
    Modesitt, Susan C.
    Parsons, Sarah J.
    GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 351 - 357
  • [9] Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis
    Ge, Zhenzhen
    Da, Yurong
    Xue, Zhenyi
    Zhang, Kai
    Zhuang, Hao
    Peng, Meiyu
    Li, Yan
    Li, Wen
    Simard, Alain
    Hao, Junwei
    Yao, Zhi
    Zhang, Rongxin
    EXPERIMENTAL NEUROLOGY, 2013, 241 : 56 - 66
  • [10] Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
    Marian Iwamoto
    Evan J. Friedman
    Punam Sandhu
    Nancy G. B. Agrawal
    Eric H. Rubin
    John A. Wagner
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 493 - 508
12345